Article Listing - Germany's Fresenius to buy US injectables group APP for up to $4.6 billion

EUROPE'S PHARMA INDUSTRY IN 1990

9 March 1992

Total pharmaceutical production in 1990 by the national member companies of the European Federation of Pharmaceutical Industries' Association in 16...

AUSTRALIAN DRUG PRICES IN LATE 91

9 March 1992

Pharmaceutical prices in Australia increased by 1.23% on average during the period from September to December 1991, according to the...

SYNTEX POSTS STRONG 2ND QTR

9 March 1992

Syntex Corp performed well in the second quarter of fiscal 1992 ended January 31, with net sales of $530.9 million,...

QUIDEL PLEASED WITH 3RD QUARTER

9 March 1992

Quidel Corporation, which merged a year ago with Monoclonal Antibodies, made sales in the third quarter ending December 31, 1991,...

TEVA PHARMA NET INCOME UP 25%

9 March 1992

Israel's leading drugmaker Teva Pharmaceuticals reported net income of NIS53.2 million ($23.3 million) for the whole of 1991. Sales for...

STUDY CONTRACT FOR EC DRUG AGENCY

9 March 1992

The Commission of the European Communities has awarded a contract for a one-year study of the requirements for the...

STOCK MARKET COMMENTARY: NEW YORK

9 March 1992

NEW YORK: was "carried forwards by a tide of cash" last week, according to Patrick Harverson of the Financial Times,...

STOCK MARKET COMMENTARY: TOKYO

9 March 1992

TOKYO: edged up in thin volume last week, to close up 2.5%. The low volume attests to the fact that...

ROMANIAN JOINT VENTURE

9 March 1992

The Romanian Doris Found-ation and an unnamed German company have set up a joint venture at an undisclosed location in...

REPLIGEN R&D PARTNERSHIP

9 March 1992

Repligen Corp of the USA has formed an R&D partnership to test and develop recombinant platelet factor-4, which has potential...

Showing 94711-94720 of 95372 articles